The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT04929951
Phase
PHASE1
Status
Recruiting

Conditions

  • Osteoarthritis Shoulder
  • Shoulder Pain

Eligibility Criteria

Sex
ALL
Age
25 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Micro Fragmented Adipose Tissue — BIOLOGICAL
    Harvesting of Micro Fragmented Adipose Tissue with intra-articular injection
  • Corticosteroid injection — BIOLOGICAL
    Sham harvesting of adipose tissue without intra-articular injection. Intra-articular injection of corticosteroid.

Study Details

This is a non-surgical trial comparing the clinical and functional outcomes of patients with osteoarthritis treated with Intra-articular injection of Micro Fragmented Adipose Tissue versus conventional therapy of intra-articular injection of corticosteroid.

Key Dates

Start date
Jul 28, 2022
Status verified
Oct 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: MFAT (Micro Fragmented Adipose Tissue)
    Intra-articular shoulder injection of autologous Micro Fragmented Adipose Tissue harvested from the thigh using tumescent lipoaspiration and processing with minimal manipulation. This harvested tissue will then be injected into the patient's shoulder.
  • Active Comparator: Conventional Therapy
    Intra-articular injection of corticosteroid (Triamcinolone 40mg)

Primary Outcome Measure

ASES Shoulder Score [ Time Frame: 24 Months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford UniversityStanfordCalifornia94305
Jessica Nguyen, BS
(650)723-0003
Elizabeth(Telsie) Jameiro, MD
(650)723-0003
Eugene Y Roh, MD (PRINCIPAL_INVESTIGATOR)
Geoffrey D Abrams, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Stanford, CA

Related Studies